Net Income Per Share (Tables)

6 Months Ended

Jun. 30, 2011

Net Income Per Share

Reconciliation Of The Numerator And Denominator Of Basic And Diluted Net Income Per Share

	Three Months Ended June 30,				Six Months Ended June 30,
	2011		2010		2011		2010
Numerator:
Net income attributable to Endo Pharmaceuticals Holdings Inc. common stockholders	$	54,583	$	51,460	$	110,370	$	111,815
Denominator:
For basic per share data — weighted average shares		116,663		116,060		116,509		116,704
Dilutive effect of common stock equivalents		2,434		600		2,352		642
Dilutive effect of 1.75% Convertible Senior Subordinated Notes and warrants		3,589		—		2,863		—
For diluted per share data — weighted average shares		122,686		116,660		121,724		117,346
Basic net income per share attributable to Endo Pharmaceuticals Holdings Inc	$	0.47	$	0.44	$	0.95	$	0.96
Diluted net income per share attributable to Endo Pharmaceuticals Holdings Inc	$	0.44	$	0.44	$	0.91	$	0.95

Reconciliation Showing The Shares Excluded From The Calculation Of Diluted Net Income Per Share

	2011		2010
Weighted average shares excluded:
1.75% Convertible senior subordinated notes due 2015 and warrants(1)		23,130		25,993
Employee stock-based awards		1,279		5,150
		24,409		31,143